focus -WSS

focus

author：knowledge 2025-09-06 03:53:08 - browse：7

Have you ever taken phenylephrine for a stuffed-up nose and then felt better? If so, you might have been perplexed when Food and Drug Administration experts recently said that that the drug — which is in some versions of DayQuil, Sudafed, and other medicines — is no more effective than a placebo.

But to Michael H. Bernstein, an assistant professor of diagnostic imaging at the Warren Alpert Medical School of Brown University, it all makes sense. Bernstein says that “no better than a placebo” still means that it works, sort of. “If we expect to feel better, then we probably will,” he told me. And that complicates the idea of what medical treatment “works.”

On this episode of the “First Opinion Podcast,” we discuss the placebo effect and its counterpart, the “nocebo effect” — if you tell patients something will make them feel worse, it generally comes true. “You’re better off hearing from a doctor something to the effect of 3 out of 4 patients who take this drug have no side effects at all versus 25% of people who take this drug do get side effects,” he said.

Bernstein also shared the delightful story of how he got into the “medical expectations” field, which started with an experiment in which he had to convince underage students that they were drinking alcohol when they weren’t.

Our conversation was based on a First Opinion Bernstein recently wrote with Grayson L. Baird, “Phenylephrine is no better than a placebo. What if that’s still better than nothing?”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Diversity in clinical trials starts with building trust, experts say

WSS

H5N1 bird flu virus started spreading in cows in Texas in December

Cancer researcher Catriona Jamieson is sending tumors into space

MultiPlan and major insurers sued for alleged medical price

Biden administration opens offers in Medicare drug price negotiations

Exact Sciences stock tumbles despite strong cancer detection sales

Cybersecurity threat forces Lurie Children's to take systems offline

focus

focus

focus

Tori Bowie and the unacceptable rates of Black maternal death

Medicare drug price negotiation’s day in court

How to save PrEP access — and even expand it

Key Senate committee drafts bipartisan bill to stem drug shortages

Bright Health sells Medicare Advantage business to Molina

Cancer researcher Catriona Jamieson is sending tumors into space

Cancer drug shortages should be causing more outrage

General Catalyst, Summa Health deal will turn on physician buy

Bright Health sells Medicare Advantage business to Molina

What we need to know about Arena Bioworks

entertainment

SAMSHA loosens regulations on methadone treatment centers

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Covid misinformation case heads to Supreme Court

Orangutan used medicinal plant to treat wound, first time ever seen

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Why rehabilitation engineers need to center patients in their research

hotspot

explore

knowledge

Wikipedia